Anthrax immune globulin, human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Inotuzumab ozogamicin.
Apalutamide
The serum concentration of Inotuzumab ozogamicin can be decreased when it is combined with Apalutamide.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Inotuzumab ozogamicin.
Advertisement
BCG, Live, Connaught Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Inotuzumab ozogamicin.
BCG, Live, Tice Strain
The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Inotuzumab ozogamicin.
Belimumab
The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Belimumab.
Advertisement
Hepatitis A Vaccine, Inactivated
The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Inotuzumab ozogamicin.
Hepatitis B Surface Antigen Vaccine
The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Inotuzumab ozogamicin.
Isavuconazole
The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Isavuconazole.
Advertisement
Lumacaftor
The serum concentration of Inotuzumab ozogamicin can be decreased when it is combined with Lumacaftor.
Rabies Immune Globulin, Human
The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Inotuzumab ozogamicin.
Rabies Virus Vaccine Flury-Lep Strain
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Inotuzumab ozogamicin.
Ranolazine
The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ranolazine.
ROTAVIRUS VACCINE, LIVE
The therapeutic efficacy of Rotavirus Vaccine can be decreased when used in combination with Inotuzumab ozogamicin.
Rubella Virus Vaccine Live (wistar Ra 27-3 Strain)
The therapeutic efficacy of Rubella virus vaccine can be decreased when used in combination with Inotuzumab ozogamicin.
Salmonella enterica subsp. enterica serovar typhi
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Inotuzumab ozogamicin.
Tetanus Toxoid Vaccine, Inactivated
The therapeutic efficacy of Clostridium tetani toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Inotuzumab ozogamicin.
Typhoid Vaccine Live Ty21a
The therapeutic efficacy of Salmonella typhi ty21a live antigen can be decreased when used in combination with Inotuzumab ozogamicin.
Typhoid Vi Polysaccharide Vaccine, S typhi Ty2 strain
The therapeutic efficacy of Salmonella typhi ty2 vi polysaccharide antigen can be decreased when used in combination with Inotuzumab ozogamicin.
Varicella Virus Vaccine Live (Oka-Merck) strain
The therapeutic efficacy of Varicella Zoster Vaccine (Live/Attenuated) can be decreased when used in combination with Inotuzumab ozogamicin.
Vemurafenib
The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vemurafenib.
Yellow Fever Vaccine
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Inotuzumab ozogamicin.
Yellow-Fever Virus Vaccine, 17D-204 strain
The therapeutic efficacy of Yellow Fever Vaccine can be decreased when used in combination with Inotuzumab ozogamicin.
